Header Logo

Connection

Maureen Coetzee to Drug Monitoring

Back to Details
This is a "connection" page, showing publications Maureen Coetzee has written about Drug Monitoring.
Maureen Coetzee
Connection Strength
0,025
Drug Monitoring
  1. Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia. J Thromb Haemost. 2012 May; 10(5):773-80.
    View in: PubMed
    Score: 0,025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.